Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
基本信息
- 批准号:10733477
- 负责人:
- 金额:$ 68.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Abdominal Aortic AneurysmAddressAdultAllelesAneurysmAngiotensin IIAnimal ModelAortaAortic AneurysmApoptosisArteriesAttenuatedBlood VesselsCell DeathCell Death InductionCharacteristicsClinical MedicineContractile ProteinsCoupledCytoprotectionDataData SetDatabasesDeath RateDevelopmentDiameterDiseaseDissectionElastasesEmbryoEnzymesExtracellular Matrix DegradationGene DeliveryGene ExpressionGenesGeneticGrowthHumanHuman GeneticsHyperlipidemiaIn VitroIncidenceInflammatory ResponseInhibition of ApoptosisIronIschemiaKnock-in MouseKnock-outKnockout MiceLesionLifeLipid PeroxidationLipid PeroxidesLoxP-flanked alleleMalignant NeoplasmsMembrane LipidsModelingMolecularMusNeurodegenerative DisordersNicotineNicotinic AcidsOperative Surgical ProceduresOxidative StressPalmitic AcidsPathogenesisPathologicPathway interactionsPatientsPentoxifyllinePharmaceutical PreparationsPharmacological TreatmentPhenotypePlayReduced GlutathioneRegulationReperfusion TherapyResearchResistanceRiskRisk FactorsRoleRuptureRuptured Abdominal Aortic AneurysmRuptured AneurysmSmokingSmooth Muscle MyocytesSolidStimulusStructureTestingThoracic aortaTransgenic MiceVascular Smooth Muscleabdominal aortaadenoviral mediatedcigarette smokeepidemiology studygain of functiongender differenceglutathione peroxidasehigh riskhypercholesterolemiain vivoinhibitorknock-downlong chain fatty acidloss of functionmortalitymouse modelnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionoverexpressionpreventprotective effectprotein expressionrepairedresponsesingle-cell RNA sequencingtissue injuryvascular inflammation
项目摘要
PROJECT SUMMARY/ABSTRACT
Abdominal aortic aneurysm (AAA) is a permanent abdominal aorta expansion with high mortality but limited
treatment options. Currently, there are no effective clinical medicines to prevent, delay, or reverse the growth
or rupture of AAA, except an open or endovascular surgical repair for symptomatic aneurysms or aneurysms at
high risk for rupture. Vascular smooth muscle cells (VSMC) are crucial in maintaining vascular wall integrity
and function, while VSMC depletion is a characteristic feature of AAA. Ferroptosis is a type of programmed cell
death dependent on iron and characterized by the accumulation of lipid peroxides. Smoking is a well-
established AAA risk factor, and cigarette smoke extract induces VSMC ferroptosis. Glutathione peroxidase 4
(GPX4) has been identified as a critical inhibitor of ferroptosis and apoptosis. Human genetics and Gene
Expression Omnibus database have demonstrated that decreased GPX4 expression is associated with an
increased risk of AAA. Our preliminary studies demonstrate that GPX4 is significantly reduced in the aorta of
AAA patients and animal models. Nicotine, a well-established AAA risk factor, reduced GPX4 and SMC
contractile protein expression. We posit that AAA risk factors can result in VSMC death via an
underappreciated pathway, i.e., ferroptosis in the artery resulting in AAA formation and rupture. We generated
VSMC-specific Gpx4 knockout mice (Gpx4SMKO) by crossing Myh11-Cre with Gpx4flox/flox mice. When
subjected to aneurysm induction by angiotensin II (Ang II) coupled with hypercholesterolemia, about 50% of
Gpx4SMKO mice died due to AAA rupture. The incidence rate and maximal diameters in Gpx4SMKO mice
were larger than in Gpx4flox/flox control mice. Specific Aim 1 will define the protective effects of VSMC-specific
GPX4 in AAA using our novel VSMC-selective GPX4 transgenic mice. We will also examine the effects of
VSMC-specific Gpx4 knockout using a different murine model with perivascular application of elastase, an AAA
model that does not produce rupture. Aim 2 will determine the GPX4-dependent protective mechanisms in
VSMC using gain- and loss-of-function strategies. We will examine the effects of GPX4 on AAA-relevant
stimuli-induced cell death, VSMC phenotypic switch, and inflammatory responses in primary human and
mouse abdominal aortic smooth muscle cells. Aim 3 will define that local activation of GPX4 attenuates AAA
pathogenesis by enhancing VSMC capacity of resistance to pathologic factors. Further, we will examine
whether the GPX4 activator protects against aneurysm development and rupture. Successful completion of the
proposed studies will establish novel mechanisms regulating VSMC loss and vascular inflammation in AAA,
which are likely to advance our understanding of the AAA formation and ultimately lead to novel strategies for
treating AAA.
项目总结/摘要
腹主动脉瘤(AAA)是一种永久性腹主动脉扩张,死亡率高,
治疗方案。目前,没有有效的临床药物来预防,延迟或逆转生长
或AAA破裂,但对症状性动脉瘤或动脉瘤进行开放或血管内手术修复除外,
破裂风险高。血管平滑肌细胞(VSMC)在维持血管壁完整性方面至关重要
而VSMC耗竭是AAA的特征性特征。铁凋亡是一种程序化细胞
依赖铁的死亡,特征是脂质过氧化物的积累。吸烟是一种很好的-
建立AAA危险因素,香烟烟雾提取物诱导VSMC铁凋亡。谷胱甘肽过氧化物酶4
GPX 4是铁凋亡和细胞凋亡的重要抑制剂。人类遗传学和基因
表达综合数据库已经证明GPX 4表达的降低与
AAA风险增加我们的初步研究表明,GPX 4在主动脉中显著减少,
AAA患者和动物模型。尼古丁是一种公认的AAA风险因素,可降低GPX 4和SMC
收缩蛋白表达。我们认为AAA风险因素可通过以下途径导致VSMC死亡:
被低估的途径,即,动脉中的铁下垂导致AAA形成和破裂。我们产生
通过Myh 11-Cre与Gpx 4flox/flox小鼠杂交获得VSMC特异性Gpx 4敲除小鼠(Gpx 4SMKO)。当
血管紧张素II(Ang II)与高胆固醇血症联合诱导动脉瘤,约50%
Gpx 4SMKO小鼠由于AAA破裂而死亡。Gpx 4 SMKO小鼠的发生率和最大直径
比Gpx 4flox/flox对照小鼠大。具体目标1将定义VSMC特异性
使用我们的新型VSMC选择性GPX 4转基因小鼠在AAA中的GPX 4。我们还将研究
使用血管周围应用弹性蛋白酶(AAA)的不同鼠模型进行VSMC特异性Gpx 4敲除
不产生破裂的模型。目的2将确定GPX 4依赖的保护机制,
VSMC使用增益和功能丧失策略。我们将研究GPX 4对AAA相关的
刺激诱导的细胞死亡,VSMC表型转换,和炎症反应,在原代人类和
小鼠腹主动脉平滑肌细胞。目的3将定义GPX 4的局部激活减弱AAA
通过增强VSMC对病理因素的抵抗能力而致病。此外,我们将研究
GPX 4激活剂是否能防止动脉瘤的发展和破裂。成功完成
提出的研究将建立调节AAA中VSMC损失和血管炎症的新机制,
这可能会促进我们对AAA形成的理解,并最终导致新的策略,
治疗AAA。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yanhong Guo其他文献
Yanhong Guo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yanhong Guo', 18)}}的其他基金
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
开发基于磷脂的纳米疗法治疗腹主动脉瘤
- 批准号:
10749980 - 财政年份:2023
- 资助金额:
$ 68.91万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 68.91万 - 项目类别:
Research Grant